Neurogene Inc.

NGNE·NASDAQ·$27.10Share Price as of 11/2·$428MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/24/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report07/02/26 8-KCurrent report06/29/26 8-KCurrent report06/08/26 8-KCurrent report06/04/26

Prospectuses and Registrations

424B5Prospectus supplement07/02/26 424B5Prospectus supplement06/30/26 S-8Registration of securities for employees03/24/26 424B5Prospectus supplement08/11/25 424B3Prospectus04/01/25

Proxies

DEF 14ADefinitive proxy04/16/26 DEFA14AAdditional proxy materials04/16/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/26/24

Ownership

SC 13GBeneficial ownership10/07/26 SC 13GBeneficial ownership10/06/26 Form 4Insider transaction10/02/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

ARSAnnual report to shareholders04/16/26 ARSAnnual report to shareholders04/25/25 EFFECTRequest for effectiveness04/04/25 CORRESPCorrespondence with the SEC04/02/25 UPLOADLetter from the SEC03/31/25